Navigation Links
Biopure Announces 2008 Second Quarter Financial Results
Date:5/21/2008

CAMBRIDGE, Mass., May 21 /PRNewswire-FirstCall/ -- Biopure Corporation (Nasdaq: BPUR) today announced its financial results for the second fiscal quarter ended April 30, 2008. For the quarter, the company reported a net loss of $5.0 million, or $0.14 per common share, compared with a net loss of $6.2 million, or $0.40 per common share, for the corresponding period in 2007. Class A common shares outstanding on April 30, 2008 and 2007 were 34,971,087 and 15,591,025, respectively.

Revenues

Total revenues for the second fiscal quarter of 2008 were $902,000, including $777,000 from sales of the company's veterinary product Oxyglobin(R), $89,000 from sales of Hemopure(R) in South Africa and $36,000 in research and development expense reimbursements from the U.S. government. Total revenues for the same period in fiscal 2007 were $619,000, including $500,000 from Oxyglobin sales, $6,000 from sales of Hemopure and $113,000 from government reimbursement. Payments from the government reimburse Biopure for trauma development expenses for Hemopure and vary with the amount of reimbursable activity for the government.

Hemopure sales increased during the second fiscal quarter of 2008 due to the increasing use of the product in South Africa. Oxyglobin revenues increased during the second fiscal quarter of 2008 compared to the same period in 2007 primarily due to higher unit sales to the company's European distributor. During the second fiscal quarter of 2007, the company accounted for European sales on a consignment basis. Now the European distributor buys product for its inventory upon shipment by the company. In the U.S., a higher average selling price of Oxyglobin during the second fiscal quarter of 2008 offset lower unit sales com
'/>"/>

SOURCE Biopure Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Biopure Appoints Dechra Exclusive U.S. Distributor of Oxyglobin
2. Biopure Announces Date to Meet with UKs Medicines and Healthcare Products Agency
3. Biopure Operations Compliant With U.K. Manufacturing Guidelines
4. Biopure Appoints New Independent Auditor
5. Biopure Completes U.K. Regulatory Agency Inspection
6. Biopure Announces 2008 First Quarter Financial Results
7. Biopure Launches Updated Website
8. Biopure Announces Pricing of Equity Offering
9. Biopure Gives Update on Malaysia Joint Venture Discussions
10. NeoStem Announces Private Placement Financing to Advance Marketing Campaign; Financing Includes Investment from New England Cryogenic Center
11. Rentschler Biotechnologie Announces Cooperation with Boehringer Ingelheim
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... , Jan. 22, 2015  Transwestern | RBJ today announces ... of office space for Shire a leading biopharmaceutical company, at ... Transwestern | RBJ,s Robert Richards , president, and ... lease for the entire five-floor building at 95 Hayden Ave. ...
(Date:1/22/2015)... OH (PRWEB) January 22, 2015 Crystal Diagnostics ... today that it has received AOAC-PTM Certifications for the six ... O121, and O145; collectively referred to as STEC or the ... 1 colony forming unit (cfu) per 325 g of raw ...
(Date:1/22/2015)... January 22, 2015 Controlled Substance Compliance ... which helps companies check the legal requirements around using ... to China. , As their international operations expand ... adopting software solutions built as a result of the ...
(Date:1/22/2015)... 2015   Cypher Genomics, Inc., the leading ... SQNM ), the leading molecular diagnostics company, ... noninvasive prenatal tests (NIPT). Through this agreement, Sequenom ... to advance analysis of clinically-relevant fetal sub-chromosomal variants ...
Breaking Biology Technology:Transwestern?RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Crystal Diagnostics Awarded AOAC-PTM Accreditation for the Rapid Detection of “Big 6” E.coli Food Pathogens 2Global Compliance Service for Controlled Substances to Expand to China 2Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4
... County ... 31 Global Med Technologies(R), Inc. ("Global Med" or ... information technology company, today announced that its Wyndgate Technologies(R) ... to Laurens County Health System of Clinton, South Carolina. ...
... 2 MDCT Sub-study to be Released Concurrent with AHA ... VIAP ), a biotechnology company focused on ... and metabolic disease, today announced that an abstract on ... been accepted for a poster presentation at the American ...
... Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI , ... Amended and Restated Distribution and License Agreement with ... for the Amended and Restated Distribution and License ... and Baxter initially entered into a Distribution and ...
Cached Biology Technology:Global Med Technologies(R) Licenses 90th Site in the Southeastern U.S. 2Global Med Technologies(R) Licenses 90th Site in the Southeastern U.S. 3VIA Pharmaceuticals to Present Poster at AHA Arteriosclerosis, Thrombosis and Vascular Biology Conference 2009 2VIA Pharmaceuticals to Present Poster at AHA Arteriosclerosis, Thrombosis and Vascular Biology Conference 2009 3VIA Pharmaceuticals to Present Poster at AHA Arteriosclerosis, Thrombosis and Vascular Biology Conference 2009 4Angiotech Pharmaceuticals, Inc. announces License Agreement with Baxter International Inc. 2Angiotech Pharmaceuticals, Inc. announces License Agreement with Baxter International Inc. 3Angiotech Pharmaceuticals, Inc. announces License Agreement with Baxter International Inc. 4
(Date:1/22/2015)... ("Company") (BM&FBOVESPA: VLID3 ON), is pleased to inform its shareholders ... Washington,s Department of Licensing, in the United States, awarded ... for driver,s licenses and identification cards to its subsidiary, Valid ... start in January 2015, with enrollment and card production starting ...
(Date:1/22/2015)... WINSTON-SALEM, N.C. , Jan. 16, 2015  A man-made ... working memory and other mental capabilities in adults with ... a pilot study led by researchers at Wake Forest ... 60 adults diagnosed with amnesic mild cognitive impairment (MCI) ...
(Date:1/22/2015)... , Jan. 22, 2015 Research and Markets ... addition of the "Global Wearable Technologies Market ... Share, Overview, Trends and Forecast 2014-2020" report ... Technologies are smart devices that can be worn ...
Breaking Biology News(10 mins):Valid USA Signs Contract For Washington Driver's License Issuance 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 2
... the movement and population size changes of Kiwis, Tuatara and ... been continually studied by conservationists and scientists. It now seems ... infect them. , Dr Alexei Drummond, from The University ... global research team analysing the genetic sequences of viruses in ...
... a Senior Research Associate at the Stowers Institute for ... and an investigator with the Howard Hughes Medical Institute, ... called Snail is expressed in a cyclic fashion during ... and chick embryo. , The findings, which were ...
... been well documented that, across human cultures and in most ... females. It's simple to blame male hormones, like testosterone, for ... genes, too. , Indeed such social behavior also has a ... at the University of Virginia Health System. "The differences ...
Cached Biology News:Finding a virus is not all bad news 2Stowers scientists demonstrate mechanism of vertebral formation 2Sex chromosome genes influence aggression andmaternal behavior, say UVa researchers 2